METTL3 and esophageal squamous cell carcinoma: Our result revealed that the ablation of METTL3 significantly inhibited tumor formation and reduced the tumor weight (n = 7; p < 0.05), consistent with the results demonstrating that METTL3 knockout inhibited the cell proliferation of ESCC cells in vitro (Fig. 1O; Fig. S5A–C).